Adiponectin Gene Polymorphisms: A Case-Control Study on Their Role in Late-Onset Alzheimer's Disease Risk

Area of Science:

• Genetics
• Neuroscience
• Endocrinology

Background:

• Adiponectin, an adipose-tissue-secreted hormone, influences metabolic homeostasis.
• Emerging evidence suggests adiponectin's potential role in the pathogenesis of late-onset Alzheimer's disease (LOAD).

Purpose of the Study:

• To investigate the association between ADIPOQ gene variants, plasma adiponectin levels, and LOAD risk.
• To analyze single nucleotide polymorphisms (SNPs) within the ADIPOQ gene in a Slovak Caucasian population.

Main Methods:

• Genotyping of 18 ADIPOQ SNPs in 385 LOAD patients and 533 controls.
• Logistic regression for LOAD risk association and linear regression for adiponectin levels.
• Stratified analyses based on sex and APOE ε4 allele status.

Main Results:

• ADIPOQ variants rs822395 and rs2036373 were significantly associated with elevated total adiponectin levels.
• No significant association was found between any ADIPOQ SNPs and LOAD risk.
• Subgroup analyses for sex and APOE ε4 status did not reveal any significant associations with LOAD risk.

Conclusions:

• While adiponectin may play a role in LOAD, this study found no significant association between ADIPOQ gene variants and LOAD susceptibility.
• Specific ADIPOQ variants influence adiponectin levels but do not appear to confer risk for late-onset Alzheimer's disease in this population.